NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Structured Abstract
Objectives:
To evaluate the effectiveness and comparative effectiveness of treatments for patients with binge-eating disorder (BED) and bariatric surgery patients and children with loss-of-control (LOC) eating. Studies of BED therapies include pharmacological interventions, psychological and behavioral interventions, or combinations of approaches. We examined whether treatment effectiveness differed in patient subgroups and described course of illness for BED and LOC eating.
Data sources:
We searched MEDLINE®, EMBASE®, the Cochrane Library, Academic OneFile, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) through January 19, 2015. Eligible studies included randomized controlled trials (RCTs), nonrandomized trials, meta-analyses, and, for course of illness, cohort and case-control studies.
Review methods:
Pairs of reviewers independently selected, extracted data from, and rated the risk of bias of relevant studies; they graded the strength of evidence using established criteria. We conducted meta-analysis for some treatment outcomes.
Results:
Of 52 included RCTs of treatment; 48 concerned BED therapy. Course-of-illness evidence came from 15 observational studies. We examined four major outcomes: binge eating and abstinence, eating-related psychopathology, weight, and general psychological and other outcomes. Second-generation antidepressants (as a class), topiramate (an anticonvulsant), and lisdexamfetamine (a stimulant) were superior to placebo in achieving abstinence and reducing binge episodes and/or binge days and eating-related obsessions and compulsions. Second-generation antidepressants decreased depression. Topiramate and lisdexamfetamine produced weight reduction in study populations whose members were virtually all overweight or obese. A few formats of cognitive behavioral therapy (CBT)—therapist led, partially therapist led, and guided self-help—were superior to placebo in achieving abstinence and reducing binge frequency. CBT for BED was generally ineffective for reducing weight or depression in this population. Therapist-led CBT was not superior to either partially therapist-led CBT or structured self-help CBT for binge-eating and weight outcomes. Behavioral weight loss treatment produced greater weight loss than CBT at the end of treatment but not over the longer run. Topiramate, fluvoxamine, and lisdexamfetamine were associated with sleep disturbance, including insomnia; topiramate and lisdexamfetamine were associated with sympathetic nervous system arousal and headache. We found no evidence on bariatric surgery patients. Treatments for LOC eating in children did not achieve superior weight reduction outcomes. Evidence on the course of either illness was limited. Early adolescent BED and LOC eating predicts such behaviors in the future.
Conclusions:
BED patients may benefit from treatment with second-generation antidepressants, lisdexamfetamine, topiramate, and CBT. Additional studies should address other treatments, combinations of treatment, and comparisons between treatments; treatment for postbariatric surgery patients and children; and the course of these illnesses.
Contents
- Preface
- Acknowledgments
- Key Informants
- Technical Expert Panel
- Peer Reviewers
- Executive Summary
- Introduction
- Methods
- Results: Overview and Efficacy and Effectiveness of Interventions To Manage Patients With Binge-Eating Disorder
- Overview of Presentation of Results
- Literature Search Results
- Binge-Eating Disorder: Overview
- KQ 1 Effectiveness of Interventions for Binge-Eating Disorder
- KQ 2 Harms Associated With Treatments or Combinations of Treatments
- KQ 3 Differences in the Effectiveness of Treatments or Combinations of Treatments for Subgroups of Adults With Binge-Eating Disorder
- Results: Loss-of-Control Eating
- Results: Course of Illness
- Discussion
- References
- Appendix A Search Strategy
- Appendix B Criteria for Exclusion at the Full Text Review Stage
- Appendix C Excluded Studies
- Appendix D Risk of Bias Tables
- Appendix E Evidence Tables
- Appendix F Strength of Evidence Tables
- Appendix G Abbreviations
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services1, Contract No. 290-2012-00008-I, Prepared by: RTI International–University of North Carolina Evidence-based Practice Center, Research Triangle Park, NC
Suggested citation:
Berkman ND, Brownley KA, Peat CM, Lohr KN, Cullen KE, Morgan LC, Bann CM, Wallace IF, Bulik CM. Management and Outcomes of Binge-Eating Disorder. Comparative Effectiveness Review No. 160. (Prepared by the RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2012-00008-I.) AHRQ Publication No. 15(16)-EHC030-EF. Rockville, MD: Agency for Healthcare Research and Quality; December 2015. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
This report may periodically be assessed for the currency of conclusions. If an assessment is done, the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report.
Two of the coinvestigators on this report have a financial conflict of interest in the subject matter (ongoing grants and consultancy to a pharmaceutical company; ongoing National Institute of Mental Health grants). Neither was a reviewer of any of her own studies or any studies in the drug class in which a financial conflict of interest is held. The lead investigator, who has no affiliation or financial involvement that conflicts with the material presented in this report, made the final determination in the assessment of studies and the body of evidence. None of the other investigators have any affiliations or financial involvement that conflicts with the material presented in this report.
The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients.
This report is made available to the public under the terms of a licensing agreement between the author and the Agency for Healthcare Research and Quality. This report may be used and reprinted without permission except those copyrighted materials that are clearly noted in the report. Further reproduction of those copyrighted materials is prohibited without the express permission of copyright holders.
AHRQ or U.S. Department of Health and Human Services endorsement of any derivative products that may be developed from this report, such as clinical practice guidelines, other quality enhancement tools, or reimbursement or coverage policies, may not be stated or implied.
This report may periodically be assessed for the currency of conclusions. If an assessment is done, the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report.
Persons using assistive technology may not be able to fully access information in this report. For assistance contact vog.shh.qrha@eraChtlaeHevitceffE
- 1
5600 Fishers Lane, Rockville, MD 20857; www
.ahrq.gov
- NLM CatalogRelated NLM Catalog Entries
- Review Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.[Ann Intern Med. 2016]Review Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, Bulik CM. Ann Intern Med. 2016 Sep 20; 165(6):409-20. Epub 2016 Jun 28.
- Treatment of binge eating disorder.[Psychiatr Clin North Am. 2011]Treatment of binge eating disorder.Wilson GT. Psychiatr Clin North Am. 2011 Dec; 34(4):773-83. Epub 2011 Oct 5.
- Review Screening for Eating Disorders in Adolescents and Adults: An Evidence Review for the U.S. Preventive Services Task Force[ 2022]Review Screening for Eating Disorders in Adolescents and Adults: An Evidence Review for the U.S. Preventive Services Task ForceFeltner C, Peat C, Reddy S, Riley S, Berkman N, Middleton JC, Balio C, Coker-Schwimmer M, Jonas DE. 2022 Mar
- Review Comparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.[Eur Eat Disord Rev. 2017]Review Comparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.Peat CM, Berkman ND, Lohr KN, Brownley KA, Bann CM, Cullen K, Quattlebaum MJ, Bulik CM. Eur Eat Disord Rev. 2017 Sep; 25(5):317-328. Epub 2017 May 3.
- Review Screening and Interventions for Childhood Overweight[ 2005]Review Screening and Interventions for Childhood OverweightWhitlock EP, Williams SB, Gold R, Smith P, Shipman S. 2005 Jul
- Management and Outcomes of Binge-Eating DisorderManagement and Outcomes of Binge-Eating Disorder
- PubChem Substance for Books (Select 4863354) (1)PubChem Substance
Your browsing activity is empty.
Activity recording is turned off.
See more...